Effects of Intravitreal Faricimab 6.0 mg Injection on Functional and Anatomic Outcomes in Patients with Neovascular Age-related Macular Degeneration

被引：0
|
作者：
Pandit, Saagar [1 ]
Wakabayashi, Taku [1 ]
Mansour, Hana [1 ]
Pashaee, Bahram [2 ]
Chiang, Allen [1 ]
Hsu, Jason [1 ]
机构：
[1] Wills Eye Hosp & Res Inst, Retina, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Populat Hlth, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2235
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [11] Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration"
    Calugaru, Dan
    Calugaru, Mihai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (02) : 362 - 363
  • [12] Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
    Dan C?lug?ru
    Mihai C?lug?ru
    International Journal of Ophthalmology, 2020, (02) : 362 - 364
  • [13] Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration
    Tanaka, Asako
    Hata, Masayuki
    Tsuchikawa, Memiri
    Ueda-Arakawa, Naoko Ueda-Arakawa
    Tamura, Hiroshi
    Miyata, Manabu
    Takahashi, Ayako
    Kido, Ai
    Muraoka, Yuki
    Miyake, Masahiro
    Ooto, Sotaro
    Tsujikawa, Akitaka
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 507 - 516
  • [14] Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Junki Hoshino
    Kosuke Nakamura
    Tetsuhiro Nagashima
    Hideo Akiyama
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 2945 - 2952
  • [15] One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment
    Takahashi, Hironori
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Hashimoto, Yuto
    Yoshida, Hana
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [16] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    PHARMACEUTICS, 2023, 15 (05)
  • [17] Intravitreal bevacizumab for neovascular age-related macular degeneration
    Ladewig, M. S.
    Ziemssen, F.
    Jaissle, G.
    Helb, H. -M.
    Scholl, H. P. N.
    Eter, N.
    Bartz-Schmidt, K. U.
    Holz, F. G.
    OPHTHALMOLOGE, 2006, 103 (06): : 463 - +
  • [18] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [19] Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration" Reply
    Wu, Bing-Hui
    Wang, Bing
    Wu, Hui-Qin
    Chang, Qin
    Lu, Hui-Qin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (02) : 363 - 364
  • [20] Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept
    Machida, Akira
    Oishi, Akio
    Ikeda, Junichiro
    Kurihara, Junko
    Yoneda, Ai
    Tsuiki, Eiko
    Hirata, Yuki
    Murakami, Ryuya
    Kitaoka, Takashi
    LIFE-BASEL, 2024, 14 (04):
12345